Navigation Links
2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development

NEW YORK, April 22 /PRNewswire-USNewswire/ -- Online nominations for the 2009 Prix Galien USA, the highest industry accolade for pharmaceutical research and development, are now being accepted at through Monday, June 15, 2009.

For the first time, the Prix Galien USA will be awarded in three categories that offer broad implications for future biomedical research: best pharmaceutical agent, best biotechnology product and best medical device. All pharmaceutical and biological drugs or devices approved by the U.S. Food and Drug Administration for first or new indications between 1999 and 2008 are eligible for nomination in 2009. The new, decade-long eligibility period will permit the judges to determine both the immediate and the long-term impact these pharmaceuticals, biotechnology products and devices have had on human health and disease.

In 2008, the Prix Galien USA committee recognized Selzentry(TM) (Pfizer Inc.), Isentress(R) (Merck & Co., Inc.), Soliris(R) (Alexion Pharmaceuticals, Inc.), INFUSE(R) (Wyeth) and Revlimid(R) (The Celgene Corporation) all for applications that address pervasive illness and diseases.

The Prix Galien USA award recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines. The award committee comprises 11 individuals including six Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. The 2009 Prix Galien USA award recipients will be honored at its annual gala event on September 30, at the American Museum of Natural History in New York. Winners of the 2009 awards will automatically be eligible for the 2010 International Prix Galien award.

For details about the Prix Galien USA award and committee visit

Limited sponsorship opportunities are still available. For more information about sponsoring the 2009 awards ceremony, contact Janet Vinci at (312) 422-0405 or at

SOURCE Prix Galien USA
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prix Galien USA Announces 2008 Final Candidates
2. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
3. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. ECBC Now Accepting Applications for 2009 Minority Undergraduate Summer Internship Program
6. GBC Seeks Nominations for Regions Third Annual Bioscience Awards
7. Early-Bird Pricing Ends Soon for MichBio Expo Attendees and Exhibitors; Award Nominations Due Nov. 1
8. Digital pioneer wins national physics prize
9. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
10. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
11. Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
Post Your Comments:
(Date:11/24/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. ... will provide a corporate overview. th Annual Oppenheimer ... p.m. ET/10:00 a.m. PT . Jim Mazzola , vice ... overview. --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... ... November 24, 2015 , ... International ... and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. ... 2015, where ISPE hosted the largest number of attendees in more than a ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
(Date:11/24/2015)... -- SHPG ) announced today that Jeff Poulton ... th Annual Healthcare Conference in New York City ... EST (1:30 p.m. GMT). --> SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
Breaking Biology Technology:
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):